Thursday, February 15, 2024 1:53:35 PM
http://archive.fast-edgar.com/20240214/A3BEF62C8M22CZZ2222M2ZZZ5PKQZ2U2X262
Filed on: February 14, 2024
Baker Bros position
-------
Kiwi
Recent ATHA News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 09:00:13 PM
- Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action • GlobeNewswire Inc. • 05/17/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:10:16 PM
- Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates • GlobeNewswire Inc. • 05/15/2024 08:05:00 PM
- Athira Pharma to Participate in Upcoming May Conferences • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer • GlobeNewswire Inc. • 04/15/2024 11:00:00 AM
- Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease • GlobeNewswire Inc. • 04/11/2024 11:00:00 AM
- Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting • GlobeNewswire Inc. • 04/03/2024 11:00:00 AM
- Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference • GlobeNewswire Inc. • 03/08/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/22/2024 09:34:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:10:13 PM
- Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates • GlobeNewswire Inc. • 02/22/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 10:01:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:54:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:46:40 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 02/16/2024 09:40:35 PM
- Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS) • GlobeNewswire Inc. • 02/08/2024 09:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:38:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:36:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:11:45 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM